A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)
| Status: | Archived |
|---|---|
| Conditions: | Gastroesophageal Reflux Disease |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Multiple Dose Levels of Pumosetrag in Patients With Symptoms Associated With Gastroesophageal Reflux Disease (GERD) Receiving a Standard Refluxogenic Meal
The purpose of this study is to determine if pumosetrag is effective in treating
Gastroesophageal Reflux Disease (GERD) symptoms in patients who have a history of GERD
symptoms and are currently taking an acid suppression therapy, such as a Proton Pump
Inhibitor (PPI).
We found this trial at
5
sites
Mayo Clinic Scottsdale Mayo Clinic Arizona was the second Mayo practice to be established outside...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Lynn Health Science Institute Our mission is to provide clinical trials research and health services...
Click here to add this to my saved trials
Mayo Clinic College of Medicine Mayo Medical School enrolls a select class of 50 medical...
Click here to add this to my saved trials